全球環糊精市場規模、份額和趨勢分析報告—產業概況和2032年預測

Get Exclusive Sample PDF of this Report Here

環糊精市場規模

• 2024 年全球環糊精市場規模為3.5502 億美元，預計到 2032 年將達到 4.5323 億美元，預測期內 複合年增長率為 3.10%。
• 市場成長主要得益於對藥物製劑中溶解度和生物利用度增強的需求不斷增長，環糊精被廣泛用作功能性賦形劑，可以在各種劑型中更有效地穩定和輸送活性藥物成分
• 此外，消費者對食品、飲料和化妝品中清潔標籤、遮蓋異味和減少防腐劑成分的偏好日益增長，這使得環糊精成為一種用途廣泛且注重健康的首選添加劑。這些因素正在加速其在各行各業的應用，從而顯著促進市場擴張。

環糊精市場分析

• 環糊精是一種能夠與多種分子形成包合物的環狀寡糖，由於其能夠提高活性成分的溶解度、穩定性和控制釋放，在製藥、食品和化妝品行業中越來越重要
• 環糊精需求的不斷增長主要源於其多功能的功能優勢、在先進藥物輸送系統中日益廣泛的應用，以及消費者對注重健康和注重性能的配方中清潔標籤和功能性成分的日益偏好。
• 北美在環糊精市場佔據主導地位，2024 年的市場份額為32.5%，這得益於其在製藥、食品和化妝品行業的廣泛應用，以及先進的研發能力和對藥物配方改進的強有力的監管支持
• 由於藥品產量擴大、加工食品需求增加以及研發投資增加，預計亞太地區將成為預測期內環糊精市場成長最快的地區
• 2024年，β-環糊精憑藉其廣泛的應用、經濟高效的包合性能，佔據了67.2%的市場份額，佔據了市場主導地位。 β-環糊精因其最佳的空腔尺寸而被廣泛應用，能夠有效地包合各種客體分子，從而提高其在各種應用中的溶解度和穩定性。其在製藥和食品工業中的成熟應用進一步支撐了強勁的需求。

報告範圍和環糊精市場細分        

Get Exclusive Sample PDF of this Report Here

環糊精市場趨勢

“製藥業的新趨勢”

• 全球環糊精市場的一個重要且加速發展的趨勢是，環糊精越來越多地融入先進的藥物製劑中，以解決活性藥物成分 (API) 的溶解度、穩定性和標靶遞送挑戰。隨著越來越多的水溶性較差的藥物進入研發線，製藥公司正在積極探索和採用環糊精，以改善藥物療效和患者預後。
  • 例如，β-環糊精廣泛應用於口服、鼻腔和注射給藥系統，以提高生物利用度、減少刺激並穩定敏感化合物。同樣，羥丙基-β-環糊精 (HPβCD) 是多種 FDA 核准藥物的關鍵輔料，包括罕見疾病和腫瘤的藥物。
• The trend is further supported by the increasing approval of cyclodextrin-based formulations by regulatory authorities such as the FDA and EMA, reflecting their established safety profile and functional versatility
• Moreover, growing investments in nanotechnology and targeted therapies are encouraging R&D in cyclodextrin derivatives for specialized delivery mechanisms
• Pharmaceutical manufacturers are increasingly incorporating cyclodextrins into drug delivery strategies for sustained and controlled release, enabling dose reduction and minimizing side effects. This positions cyclodextrins as critical enablers in the development of next-generation drug formulations
• As a result, the expanding pharmaceutical applications of cyclodextrins are driving innovation and reshaping expectations around excipient performance, solidifying their role in the future of drug delivery systems

Cyclodextrins Market Dynamics

Driver

“Growing Demand for Enhanced Stability”

• The growing demand for enhanced stability across pharmaceutical, food, and cosmetic applications is a significant driver for the cyclodextrins market, as these compounds are increasingly used to protect sensitive ingredients from degradation caused by light, heat, and oxidation
  • For instance, hydroxypropyl-beta-cyclodextrin is widely employed in injectable drug formulations to improve the chemical and physical stability of APIs, extending shelf life and maintaining therapeutic efficacy
• As manufacturers seek to ensure consistent product quality and performance throughout distribution and storage, cyclodextrins provide a reliable solution by forming inclusion complexes that encapsulate and stabilize active molecules
• Furthermore, in the food and beverage industry, cyclodextrins are used to stabilize flavors, vitamins, and essential oils that would otherwise degrade quickly, allowing for the development of more durable and appealing functional products. The cosmetics industry also leverages cyclodextrins to preserve the integrity of volatile or sensitive active ingredients, enhancing the performance and longevity of skincare and personal care formulations
• This rising focus on product stability, combined with increasing consumer expectations for safe and effective products with extended shelf life, is driving the adoption of cyclodextrins as essential stabilizing agents across diverse end-use sectors

Restraint/Challenge

“Presence of Competitive Alternatives”

• The presence of competitive alternatives such as polymer-based carriers, nanoemulsions, liposomes, and other encapsulation technologies poses a significant challenge to the broader adoption of cyclodextrins across end-use industries
  • For instance, liposomes and solid lipid nanoparticles are gaining traction in pharmaceutical and cosmetic applications due to their ability to enhance solubility and bioavailability while offering biocompatibility and controlled release properties
• These alternatives often offer distinct functional advantages, such as higher loading capacity or targeted delivery capabilities, making them appealing substitutes in specific formulations or advanced drug delivery systems. In addition, in the food industry, alternative stabilizers and encapsulation materials such as maltodextrin, gums, and modified starches are widely available and often more cost-effective, especially for manufacturers operating in price-sensitive markets
• While cyclodextrins are highly effective and generally recognized as safe (GRAS), their comparatively higher production cost and complex extraction or derivatization processes can limit their competitiveness against simpler or more economical alternatives
• Overcoming this challenge requires continued innovation in cyclodextrin manufacturing to reduce production costs, as well as increased awareness among formulators of their multifunctional benefits in enhancing product stability, solubility, and safety across sectors

Cyclodextrins Market Scope

The market is segmented on the basis of product type, alcoholic content, flavor, category, packaging, and distribution channel.

• By Product Type

By Product Type On the basis of product type, the cyclodextrins market is segmented into alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin, and cyclodextrin derivatives. The beta-cyclodextrin segment dominates the largest market revenue share of 67.2% in 2024, driven by its widespread availability, cost-effectiveness, and versatile inclusion capabilities. Beta-cyclodextrin is extensively used due to its optimal cavity size, which effectively encapsulates a wide range of guest molecules, enhancing solubility and stability in various applications. Its well-established use in pharmaceuticals and food industries further supports strong demand.

The cyclodextrin derivatives segment is anticipated to witness the fastest growth rate from 2025 to 2032, fueled by increasing research and development focused on improving solubility, bioavailability, and functional properties. Derivatives such as hydroxypropyl-beta-cyclodextrin and methyl-beta-cyclodextrin are gaining traction for specialized applications in drug delivery and cosmetics, where enhanced performance and safety profiles are critical.

• By Application

On the basis of application, the cyclodextrins market is segmented into food, beverages, pharmaceuticals, cosmetics, chemicals, and others. The pharmaceuticals segment accounted for the largest market revenue share in 2024, driven by the growing demand for drug delivery solutions that improve solubility, stability, and controlled release of active ingredients. Cyclodextrins are extensively used to formulate more effective and safer pharmaceutical products, contributing to their dominant position.

The food segment is expected to witness the fastest CAGR from 2025 to 2032, supported by rising consumer preference for functional foods and natural additives. Cyclodextrins enhance flavor retention, reduce off-notes, and stabilize volatile compounds in food products, encouraging their increased use in processed foods and beverages. Growing awareness of health benefits and clean-label trends further stimulate growth in this segment.

Cyclodextrins Market Regional Analysis

• North America dominated the cyclodextrins market with the largest revenue share of 32.5% in 2024, driven by extensive use in pharmaceuticals, food, and cosmetics industries, alongside advanced R&D capabilities and strong regulatory support for drug formulation improvements
• The region’s established pharmaceutical sector utilizes cyclodextrins to enhance drug solubility and stability, while demand for clean-label and functional ingredients in food and cosmetic applications also contributes to market expansion
• Robust infrastructure, the presence of key industry players, and a favorable innovation ecosystem continue to reinforce North America’s leadership in the cyclodextrins market

U.S. Cyclodextrins Market Insight

U.S. cyclodextrins market captured most of the North American revenue share in 2024, supported by the nation’s mature pharmaceutical industry and growing applications in food and beverage formulations. The increasing emphasis on bioavailability enhancement in drug delivery, combined with a rising preference for functional food ingredients, drives cyclodextrin demand. Ongoing FDA approvals and research into cyclodextrin derivatives for targeted therapies further strengthen market prospects.

Europe Cyclodextrins Market Insight

The Europe cyclodextrins market is projected to grow at a robust CAGR through 2032, fueled by increasing demand in pharmaceutical, cosmetic, and personal care formulations. EU regulations promoting excipients with improved safety and performance profiles support the incorporation of cyclodextrins in novel drug delivery systems. In addition, growing health awareness and consumer preference for odor-masking and stabilization in food and cosmetic products are driving adoption.

Germany Cyclodextrins Market Insight

Germany holds a significant share of the European cyclodextrins market, benefiting from a strong pharmaceutical manufacturing base and high standards for product stability and efficacy. German companies are actively investing in research on cyclodextrin derivatives for specialty drugs, while the country’s proactive approach to food safety and sustainability is encouraging wider use in functional foods and eco-friendly formulations.

Asia-Pacific Cyclodextrins Market Insight

預計亞太地區將在2025年至2032年期間實現最快的複合年增長率，這得益於藥品產量的擴大、加工食品需求的增長以及中國、日本和印度等國家研發投入的增加。政府對藥品創新的支持以及向高端化妝品成分的轉變，將進一步加速市場成長。

中國環糊精市場洞察

2024年，中國佔據亞太地區最大的市場份額，這得益於其作為環糊精主要生產國和出口國的地位。由於國內生產能力和極具競爭力的價格，中國快速發展的製藥和食品加工產業是其主要貢獻者。環糊精在中藥和功能性食品中的應用日益廣泛，也凸顯了其主導地位。

日本環糊精市場洞察

日本在先進的藥物和化妝品配方中對環糊精的需求日益增長，這得益於其強大的創新文化和消費者對產品品質的高期望。環糊精廣泛應用於健康和個人護理領域，以延長保質期、提高穩定性和提高遞送效率。日本對老齡化人口健康解決方案的關注進一步增強了其在藥物配方方面的需求。

環糊精市場份額

環糊精產業主要由知名公司主導，包括：

• CTD Holdings, Inc.（美國）
• 瓦克化學股份公司（德國）
• Cyclolab（匈牙利）
• 默克集團（德國）
• 日本食品化工株式會社（日本）
• 羅蓋特兄弟公司（法國）
• 阿什蘭（美國）
• 山東鑫達生物科技有限公司 (中國)
• 鬱南縣永光集團（中國）
• 孟州市鴻基生物有限公司 (中國)
• Gangwal Chemicals Pvt. Ltd.（印度）
• 吉諾（挪威）
• 豐臣集團股份有限公司 (中國)
• 開曼化學公司（美國）
• 中蘭實業股份有限公司 (中國)
• 山東濱州致遠生物科技有限公司 (中國)
• Captisol（美國）

全球環糊精市場的最新發展

• 2023年5月，瓦克在2023上海國際酒店用品展覽會上推出了CAVAMAX泡沫頂料粉，展示了一種創新的固體飲料配方，該配方利用環糊精，為茶、牛奶和植物基替代品等各種飲料打造順滑穩定的泡沫頂料。儘管該產品目前僅限於中國市場銷售，但它凸顯了環糊精在功能性食品和飲料應用領域的不斷擴展，並透過提升口感和消費者吸引力的增值配方來支持市場成長。
• 瓦克化學股份有限公司於2020年7月推出了CAVAMAX W6，這是一款源自再生原料的品牌α-環糊精。此α-環糊精含有六個葡萄糖單元，在提高藥物和食品配方的溶解性、穩定性和生物利用度方面具有顯著潛力。 CAVAMAX W6的商業化體現了人們對永續高效能輔料日益增長的關注，有助於環糊精在醫療相關產品和消費品領域的更廣泛應用。

SKU-46219